If you require further searching capabilities for announcements please email: data@nzx.com

Notification of Issue of Securities

15/09/2017, 08:51 NZST, SECISSUE

NOTIFICATION OF ISSUE OF SECURITIES Auckland, New Zealand, 15 September 2017 - Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) advises that the following securities were issued pursuant to the Company's 2014 issue of Options under the Fisher & Paykel Healthcare 2003 Share Option Plan and the Company's 2014 issue of Performance Share Rights (PSRs). The issue of Options and shares under the Option Plan was approved by the Board on 20 August 2014. The issue of shares under the PSR plan was approved by the Board on 20 August 2014. (a) Class of security Ordinary Shares ISIN NZFAPE0001S2 (b) Number issued 17,345 (c) Issue price Options: $4.88 (7,945 shares) PSRs: $Nil (9,400 shares) (d) Payment terms Nil refer (g) below (e) Amount paid up In full (f) Percentage of total class issued 0.00304% (g) Reason for issue Employee cancelling Options issued under the 2014 issue of the Fisher & Paykel Healthcare 2003 Share Option Plan. 12,750 Options were cancelled on 15 September 2017 pursuant to the Cancellation Offer approved by shareholders at the ASM held on 12 August 2004. 7,945 shares were issued in consideration of the cancellation of the Options and are equal in value to the gain on the Options (such gain being calculated based on an exercise price of $4.88). Employees exercising PSRs issued under the 2014 issue of the Fisher & Paykel Healthcare Performance Share Rights Plan. 9,400 PSRs were exercised on 15 September 2017 and 9,400 shares were issued. (h) Authority for issue Directors' resolution (i) Terms of issue The shares rank pari passu with the existing ordinary shares. (j) Total number of securities after issue 570,214,506 (l) Date of issue 15 September 2017 This advice is given under Listing Rule 7.12.1. End CA:00307250 For:FPH Type:SECISSUE Time:2017-09-15 08:51:09

Downloads

Historical Announcement's attachments older than 7 years are not available on this platform